Dr. Subei is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8390 Lyndon B Johnson Fwy
Suite 1000
Dallas, TX 75243Phone+1 214-750-9977Fax+1 214-750-9983
Summary
- Dr. Adnan Subei is a neurologist in Dallas, TX practicing at Neurology Consultants of Dallas. He received his medical degree from Lake Erie College of Osteopathic Medicine and has been in practice 9 years. He also speaks multiple languages, including Arabic. He specializes in neuroimmunology/multiple sclerosis and is experienced in neuro visual disorders.
Education & Training
Cleveland Clinic FoundationFellowship, Allergy and Immunology, 2014 - 2015
Sparrow Hospital/Michigan State UniversityResidency, Neurology, 2011 - 2014- Sparrow Hospital/Michigan State UniversityInternship, Transitional Year, 2010 - 2011
University of Texas Southwestern Medical CenterPost-Doctoral Fellowship, 2009 - 2010
Michigan State UniversityPost-Doctoral Fellowship, Neuro-Ophthalmology, 2008 - 2009
Lake Erie College of Osteopathic Medicine - Seton HillClass of 2008
Certifications & Licensure
FL State License 2015 - 2026
TX State License 2017 - 2026
OH State License 2012 - 2024
MI State License 2010 - 2014- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 105 citationsSphingosine 1-Phosphate Receptor Modulators in Multiple SclerosisAdnan M. Subei, Jeffrey A. Cohen
CNS Drugs. 2015-08-04 - 23 citationsRetinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sc...Ethan Meltzer, Peter Sguigna, Adnan Subei, Shin C. Beh, Eric J. Kildebeck
JAMA Neurology. 2017-05-01 - 16 citationsRisk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple SclerosisAdnan M. Subei, Daniel Ontaneda
CNS Drugs. 2015-09-25
Grant Support
- Clinical Care Physician FellowshipNational Multiple Sclerosis Society2014–Present
Professional Memberships
- Member
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
